Transcriptomics,Genomics

Dataset Information

110

Network integrative genomic and transcriptomic analysis of carbapenem-resistant Klebsiella pneumoniae strains identifies genes for resistance and virulence


ABSTRACT: With global increase in use of carbapenems, several gram-negative bacteria have acquired carbapenem resistance, thereby limiting treatment options. Klebsiella pneumoniae is one of such notorious pathogen that is being widely studied to find novel resistance mechanisms and drug targets. These antibiotic-resistant clinical isolates generally harbor many genetic alterations, and identification of causal mutations will provide insights into the molecular mechanisms of antibiotic resistance. We propose a method to prioritize mutated genes responsible for antibiotic resistance, in which mutated genes that also show significant expression changes among their functionally coupled genes become more likely candidates. For network-based analyses, we developed a genome-scale co-functional network of K. pneumoniae genes, KlebNet (www.inetbio.org/klebnet). Using KlebNet, we could reconstruct functional modules for antibiotic-resistance, and virulence, and retrieved functional association between them. With complementation assays with top candidate genes, we could validated two genes for negative regulation of meropenem resistance and four genes for positive regulation of virulence in Galleria mellonella larvae. Therefore, our study demonstrated feasibility of network-based identification of genes required for antimicrobial resistance and virulence of human pathogenic bacteria with genomic and transcriptomic profiles from antibiotic-resistant clinical isolates. Overall design: We used two strains of K. pneumoniae clinical isolates from a single patient who had undergone meropenem treatment: K26 and K56 that were isolated before and after the meropenem administration, respectively. A significant increase in meropenem minimum inhibitory concentration (MIC) was observed in K56 compared with K26 from 0.5 µg/ml to ≥16 µg/ml. We also generated a mutant strain that acquired meropenem resistance during in vitro culture condition. The meropenem-susceptible K. pneumoniae strain K26 was used as the parent strain to obtain in vitro meropenem-resistant mutants. The resistant strains were isolated at wide range of meropenem concentrations, a strain K26M used in this study was obtained at the concentration of 16 µg/ml of meropenem.

INSTRUMENT(S): Illumina HiSeq 2500 (Klebsiella pneumoniae)

SUBMITTER: Muyoung Lee  

PROVIDER: GSE115539 | GEO | 2018-06-10

REPOSITORIES: GEO

Similar Datasets

2011-04-21 | E-MEXP-3170 | ArrayExpress
2018-11-30 | PXD010389 | Pride
2011-04-08 | GSE26353 | GEO
2014-08-18 | E-GEOD-46887 | ArrayExpress
2011-04-08 | E-GEOD-26353 | ArrayExpress
2012-10-29 | E-BUGS-128 | ArrayExpress
| GSE87627 | GEO
2010-07-07 | GSE21355 | GEO
2010-07-07 | E-GEOD-21355 | ArrayExpress
2011-12-01 | E-BUGS-126 | ArrayExpress